Savita Rangarajan

Publications

85 publications

Page 4 of 9

Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq®) in adults with severe haemophilia A: efficacy and safety

T. Lissitchkov,

K. Hampton,

M. Von Depka,

C. Hay,

S. Rangarajan,

E. Tuddenham,

K. Holstein,

A. Huth-kühne,

I. Pabinger,

S. Knaub,

J. Bichler,

& J. Oldenburg

, 2016 , Haemophilia , 22 (2) , 225--231

DOI: 10.1111/hae.12793

Type: article

The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO

P. Collins,

E. Chalmers,

P. Chowdary,

D. Keeling,

M. Mathias,

J. O'donnell,

K. J. Pasi,

S. Rangarajan,

& A. Thomas

, 2016 , Haemophilia , 22 (4) , 487--498

DOI: 10.1111/hae.13013

Type: article

Long-term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A

B. Nolan,

J. Mahlangu,

D. Perry,

G. Young,

R. Liesner,

B. Konkle,

S. Rangarajan,

S. Brown,

H. Hanabusa,

K. J. Pasi,

I. Pabinger,

S. Jackson,

L. M. Cristiano,

X. Li,

G. F. Pierce,

& G. Allen

, 2016 , Haemophilia , 22 (1) , 72--80

DOI: 10.1111/hae.12766

Type: article

Clinical overview of Fanhdi/Alphanate (plasma-derived, VWF-containing FVIII concentrate) in immune tolerance induction in haemophilia A patients with inhibitors

V. Jiménez-Yuste,

J. Oldenburg,

S. Rangarajan,

M. H Kurth,

J. Bozzo,

& E. Santagostino

, 2016 , Haemophilia , 22 (1) , e71--e74

DOI: 10.1111/hae.12857

Type: article

Nonacog beta pegol in previously treated children with hemophilia B: results from an international open-label phase 3 trial

M. Carcao,

M. Zak,

F. Abdul Karim,

H. Hanabusa,

S. Kearney,

M.-y. Lu,

P. Persson,

S. Rangarajan,

& E. Santagostino

, 2016 , Journal of Thrombosis and Haemostasis , 14 (8) , 1521--1529

DOI: 10.1111/jth.13360

Type: article

Long-acting recombinant factor VIII Fc fusion protein (rFVIIIFc) for perioperative haemostatic management in severe haemophilia A

Johnny Mahlangu,

Margaret Ragni,

Naresh Gupta,

Savita Rangarajan,

Robert Klamroth,

Johannes Oldenburg,

Keiji Nogami,

Guy Young,

Lynda Cristiano,

Yingwen Dong,

Geoffrey Allen,

Glenn Pierce,

& Brian Robinson

, 2016 , Thrombosis and Haemostasis , 116 (07) , 1--8

DOI: 10.1160/TH15-10-0780

Type: article

Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A

Paul Batty,

Gary W Moore,

Sean Platton,

James C Maloney,

Ben Palmer,

Louise Bowles,

K John Pasi,

Savita Rangarajan,

& Daniel P Hart

, 2015 , Thrombosis and Haemostasis , 114 (4) , 804--811

DOI: 10.1160/TH14-12-1062

Type: article

[Accepted Abstracts: 2015 Scientific Symposium of the Hemostasis and Thrombosis Research Society April 16-18, 2015 New Orleans, Louisiana] Pharmacokinetic (PK) Comparison of Two Fibrinogen Concentrates for the Treatment of Congenital Fibrinogen Deficiency

Savita Rangarajan,

M. Karimi,

B. Schwartz,

Sigurd Knaub,

& Flora Peyvandi

, 2015 , Haemophilia , 21 (3) , e271--e272

Type: conference

The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full‐length to B‐domain‐deleted factor VIII: a prospective cohort comparison

C. R. M. Hay,

B. P. Palmer,

E. A. Chalmers,

D. P. Hart,

R. Liesner,

S. Rangarajan,

K. Talks,

M. Williams,

& P. W. Collins

, 2015 , Haemophilia , 21 (2) , 219--226

DOI: 10.1111/hae.12563

Type: article

Inhibitors in nonsevere haemophilia A

Alice S van Velzen,

Corien L Eckhardt,

Daniel P Hart,

Marjolein Peters,

Savita Rangarajan,

Maria Elisa Mancuso,

Frans J Smiers,

Kate Khair,

Pia Petrini,

Victor Jiménez-Yuste,

Charles R M Hay,

Johanna G van der Bom,

Thynn T Yee,

& Karin Fijnvandraat

, 2015 , Thrombosis and Haemostasis , 114 (1) , 46--55

DOI: 10.1160/TH14-11-0940

Type: article

Dr Savita Rangarajan

Connect with Savita

Publications